Related by context. All words. (Click for frequent words.) 74 Genotypes 69 Polymorphism 68 Hepatitis B Virus 67 Phenotype 67 Gene Mutation 66 Subtype 66 Genetic Variation 66 Polymorphisms 66 Antitumor 66 genotype 65 Leukemias 65 Supplemental Figure 65 Chronic Hepatitis C 65 Mouse Model 64 Respiratory Virus 64 Disease Progression 64 Infected Patients 64 Clinical Outcome 64 Subtypes 63 Adjuvant Chemotherapy 63 clade B 63 Lymphocyte 63 Placebo Controlled Trial 63 Immune Responses 63 Severe Asthma 63 Immunogenicity 62 Treating Chronic 62 Chronic HCV 62 Antigens 62 Estrogen Receptor 62 Protein Synthesis 62 Viral Load 62 Virus Infection 62 Insulin Resistance 62 Protease Inhibitors 62 rs# [001] 62 Lymphocytic 62 Pooled Analysis 62 Herpes Virus 62 seronegative 62 Inhibits 62 Circulating Tumor Cells 62 Randomized Study 62 Combination Therapy 62 Apolipoprotein 62 Meta Analysis 62 HCV genotype 62 Gene Variants 62 HCV genotypes 62 Inactivation 62 Chemokine Receptor 62 Drug Resistant 61 Kidney Function 61 Pharmacokinetic Study 61 Tumor Suppressor 61 Epitopes 61 Antiviral Therapy 61 Dengue Virus 61 cagA 61 Dendritic Cells 61 Autoantibodies 61 Poliovirus 61 Phenotypes 61 Breast Cancer Recurrence 61 Virulence 61 Transcription Factor 61 Epidermal Growth Factor Receptor 61 Tyrosine Kinase 61 Cytoplasmic 61 Antiviral Activity 61 Progenitor Cells 61 Breast Cancer Cells 61 Janus kinase 61 Controlled Trial 61 Cytogenetic 61 Ischemic 61 Signaling Pathway 61 Transmembrane 61 Antitumor Activity 61 Cytochrome P# 61 Genetic Marker 61 Vitro Activity 61 Gastric Cancer 61 Relapsing Remitting Multiple Sclerosis 61 Susceptibility 61 Brain Metastases 60 Chronic Pelvic Pain 60 Vaccine Candidate 60 Autoimmune Diseases 60 Modulates 60 Phosphorylation 60 Peginterferon Alfa 2a 60 Renal Function 60 Inflammatory Markers 60 Tyrosine Kinase Inhibitor 60 CC genotype 60 Factor Receptor 60 Allogeneic 60 Oral Fingolimod 60 Anti Tumor Activity 60 Secretory 60 #q#.# [001] 60 HLA DRB1 * 60 HCV Genotype 60 Binding Protein 60 Haplotype 60 Improves Outcomes 60 Gene Variant 60 Neuroprotection 60 Polymerase 60 Genetic Mutation 60 Prospective Randomized 60 serovar 60 Aggressive Prostate Cancer 60 Inflammatory Pain 60 Neutralizing Antibodies 60 Mutational 60 Supplementary Table 60 Mesenchymal Stem Cells 60 Tumor Cells 60 Postmenopausal Women 60 Glycosylation 60 Metastatic Colorectal Cancer 60 Herpes simplex virus 60 Atypical Hemolytic Uremic Syndrome 60 Alleles 60 Subunit 60 Fracture Risk 60 Quantitation 60 Prostatic 60 Breast Cancers 60 Lymphoid 60 Angiogenic 60 Genital Herpes 60 Mutation 60 Monoclonal Antibody 60 Metastatic Renal Cell Carcinoma 60 Adenoviral 60 Shows Promise Against 59 Monotherapy 59 Cell Proliferation 59 Histone 59 Immunosuppression 59 activating mutation 59 Hepatocellular Carcinoma 59 Germline 59 Nucleoside 59 Plasmodium vivax 59 Prostate Biopsy 59 Mutagenesis 59 Epstein Barr Virus EBV 59 Interferon Beta 59 Alkaline Phosphatase 59 Histologic 59 Follicular Lymphoma 59 Retrovirus 59 VNTR 59 Endothelial Cells 59 Novel Therapeutic 59 Peripheral Blood 59 NRTI resistance 59 Secretion 59 Randomized Phase 59 Tumor Cell 59 Iron Overload 59 Dendritic Cell 59 Viral Suppression 59 HBV genotype 59 Castration Resistant Prostate Cancer 59 Intervention Trial 59 Macrophage 59 KRAS mutation 59 Hematopoietic Stem Cells 59 Mutation Analysis 59 aminotransferase 59 Relapsed Refractory 59 Protein Interactions 59 Sustained Virologic Response 59 Treatment Naive HIV 59 Influenza Virus 59 Induces 59 Comorbidities 59 Left Ventricular 59 variant allele 59 Conjugate 59 Targeted Therapy 59 idiopathic myelofibrosis 59 HLA DR4 59 Dose Escalation 59 Serotype 59 methylenetetrahydrofolate reductase 59 Novel Inhibitor 59 Universal Flu Vaccine 59 HCV SPRINT 59 Oncogenic 59 Conformational 59 Synthase 59 Orally Active 59 Non Alcoholic Fatty 59 Ribosomal 59 Infectivity 59 Renal Cell Carcinoma 59 Genetic Predisposition 59 Asymptomatic 59 missense mutations 59 Genes Linked 59 TIMP 1 59 Critically Ill Patients 59 Human Monoclonal Antibody 59 Pathogenicity 59 Smooth Muscle 59 #p# [003] 59 methyltransferase 59 homozygotes 59 Cardiac Function 59 Kinase Inhibitors 59 Localized Prostate Cancer 59 Inhaled Corticosteroids 59 Rotavirus Vaccine 59 Anti Tumor 59 Tumor Suppressor Gene 59 Squamous 59 Protease 59 NY ESO 58 Prognostic Factors 58 Oxidative Stress 58 Secretase 58 TIMP 58 Gene Expression 58 Beta Amyloid 58 PTPN# 58 Chlamydia trachomatis 58 apolipoprotein E gene 58 Cardiac Troponin 58 Drug Candidate 58 KIF6 gene 58 Demonstrated Significant 58 Protein Kinase 58 Pediatric Patients 58 Epithelial Cell 58 Breast Carcinoma 58 Unresectable 58 Multidrug Resistance 58 Prolongs Survival 58 Hybrid Capture 58 Eukaryotic 58 Erythropoietic 58 Fibrinogen 58 gastric adenocarcinoma 58 Transcriptome 58 Antibiotic Resistant 58 Insulin Sensitivity 58 Systolic Blood Pressure 58 Signaling Pathways 58 Premature Aging 58 Heterogeneity 58 Cognitive Impairment 58 Cardiovascular Events 58 Rheumatoid Arthritis Patients 58 Metabolites 58 Improve Survival 58 JAK2 V#F 58 Prognostic Value 58 Sipuleucel T 58 Metastatic Prostate Cancer 58 Anticoagulant 58 serogroup 58 Adenoma 58 Malignancies 58 Disease Causing 58 Immunogenic 58 TB Vaccine 58 Genetic Variations 58 Genetic Defect 58 clade C 58 Cancer Incidence Mortality 58 CYP#C# [002] 58 Prognostic Significance 58 Highly Pathogenic 58 pT2 58 Histopathologic 58 Attenuates 58 Metastases 58 PEG IFN 58 Ranolazine 58 Ischemic Stroke 58 Genetic Variants 58 Statistically Significant 58 Bone Mineral Density 58 HLA B# 58 Cytotoxicity 58 MLH1 58 Cell Adhesion 58 ABCB1 58 ALK mutations 58 Investigational Agent 58 Dehydrogenase 58 Interferon Alfa 58 Prevalence Worldwide 58 Transgenic Mice 58 Glucose Metabolism 58 Hypertensive Patients 58 Experimental Vaccine 58 Prostate Cancer Patients 58 Cancer Biomarkers 58 Aurora Kinase 58 Non Inferiority 58 Randomized Trials 58 Phase 2b Study 58 Isolates 58 Platelet Function 58 Glioma 58 Allele 58 breast carcinomas 58 Hemodialysis Patients 58 Prognostic 58 Human Leukocyte Antigen 58 Preclinical Models 58 See CLINICAL PHARMACOLOGY 58 Preclinical Study 58 Immunoassays 58 Bioavailability 58 Genetic Variant 58 Myocardial Ischemia 58 Multiple Myeloma Patients 58 Combination Treatment 58 Overactive Bladder 58 pneumococcal serotypes 58 genotypes 58 Proliferative 58 IgA deficiency 58 Systemic Delivery 58 coxsackievirus 58 Therapeutic Effects 58 Human Monoclonal Antibodies 58 Cerebrospinal Fluid 58 Gene Linked 58 Colon Polyps 58 Epitope 58 Subgroup Analysis 58 Skeletal Muscle 58 Unfractionated Heparin 57 Disease Severity 57 rs# [004] 57 Researchers Identify 57 HER2 HER3 57 Telomere Length 57 Naive Patients 57 Predict Prostate Cancer 57 Lymphocytes 57 Structure Function 57 Nonalcoholic Fatty Liver Disease 57 Diabetic Patients 57 Reductase 57 Mouse Models 57 virulence genes 57 Pharmacogenomic 57 Upregulation 57 Solid Tumors 57 Preterm Delivery 57 Integrin 57 Advanced Melanoma 57 Transcriptional 57 Phosphatase 57 Specificity 57 methicillin susceptible Staphylococcus aureus 57 Trypanosoma brucei 57 P. ovale 57 Her2/neu 57 Patient Populations 57 Respiratory Syncytial Virus 57 hepatoma 57 Genes Associated 57 Pharmacodynamics 57 Viral Infection 57 IL#B 57 Cytomegalovirus 57 Phenotypic 57 Herpesvirus 57 Herpes Simplex Virus 57 HTLV 57 Epithelial 57 Genetic Markers 57 Potent Inhibitor 57 T2DM 57 Lipid Levels 57 Septic Shock 57 Nedd4 57 SSc 57 Apolipoprotein E 57 Nucleotide 57 orthologs 57 Systematic Review 57 D Dimer 57 Protein Linked 57 Assay Kit 57 Vertebral Fractures 57 Endometrial Cancer 57 Polymorphic 57 fluconazole resistant 57 #beta hydroxysteroid dehydrogenase 57 genotype 1a 57 Invasive Fungal Infections 57 Colorectal Cancer Patients 57 Serologic 57 Mutation Detection 57 Adenovirus 57 Prostate Cancer Cells 57 DNA Methylation 57 Prophylactic Treatment 57 Neoplasms 57 Breast Tumors 57 #S rRNA 57 Suppresses 57 Previously Treated 57 Tumor Targeting 57 Initiated Phase 57 Virus Infections 57 cytopathic 57 UGT#A# * 57 Immunohistochemical analysis 57 allele frequencies 57 Tumor Response 57 KRAS mutations 57 Glycoprotein 57 BRAF V#E 57 HBsAg 57 CagA 57 seropositivity 57 Improves Survival 57 promoter polymorphism 57 Late Breaker 57 Trichomonas vaginalis 57 Cancer Cells 57 Growth Hormone Deficiency 57 Community Acquired Pneumonia 57 Efficacious 57 Immunostimulatory 57 Immune Cell 57 Adenomas 57 GSTP1 57 ESR1 57 Malaria Parasite 57 Clinical Trial Results 57 BVDV 57 Genotypic 57 heterozygotes 57 Immunologic 57 Single Nucleotide Polymorphisms 57 Epstein Barr Virus 57 Systemic Sclerosis 57 Interferon gamma 57 COL#A# 57 Conserved 57 Tumor Markers 57 Genes Involved 57 Clinical Efficacy 57 Predict Breast Cancer 57 IgG4 57 Chemotherapy Induced 57 Adjuvant Therapy 57 Cardiovascular Outcomes 57 DQB1 * 57 Radical Prostatectomy 57 H pylori 57 UGT#A# 57 Elderly Patients 57 Gram Negative 57 Survival Benefit 57 Protein Expression 57 CT Angiography 57 Potency 57 Coronary Arteries 57 Randomised 57 IgG1 57 C. trachomatis 57 Tumor Growth 57 stage IIIB 57 Staphylococcal 57 Soft Tissue Sarcoma 57 Suppl. 57 Autologous Stem Cell Transplantation 57 Test Detects 57 Cancer Genetic Markers 56 Phase IIb Trial 56 ApoE 56 genotyped 56 Neural Stem Cells 56 urothelial carcinoma 56 Cytomegalovirus CMV 56 Benign Prostatic Hyperplasia 56 VKORC1 56 Parainfluenza 56 AnaSpec Introduces 56 K ras mutations 56 Predisposition 56 Genetic Testing 56 von Hippel Lindau 56 replicase 56 Inhibitory 56 surgically resected 56 PIK3CA 56 Genetic Disorder 56 Retroviral 56 K#N 56 Appears Safe 56 Combo Therapy 56 Multicenter Study 56 Shows Efficacy 56 SNP rs# [001] 56 Reproducibility 56 Proves Effective 56 Antigenic 56 Premature Infants 56 Bacterial Infections 56 intraepithelial neoplasia 56 Receptor Antagonists 56 replicon 56 ADPKD 56 Clinically Significant 56 HBeAg negative 56 Clinical Relevance 56 DENV 56 Venous Thrombosis 56 #p# [001] 56 Vaccine Adjuvant 56 K#R [002] 56 Androgen Receptor 56 Pegylated 56 Kidney Transplants 56 Thrombotic 56 genotypic 56 Neoplastic 56 diabetes mellitus DM 56 promoter methylation 56 Long Term Efficacy 56 TP# mutations 56 Hepatocyte 56 Flu Virus 56 Shows Promising 56 Neoadjuvant Chemotherapy 56 Knee Osteoarthritis 56 Leukemia Cells 56 Watchful Waiting 56 Dysregulation 56 Cytotoxic T 56 Genetic Diversity 56 Radiation Induced 56 Resistant TB 56 FLT3 56 Lowers Risk 56 AAT Deficiency 56 Innate Immune 56 Abdominal Fat 56 MTHFR gene 56 Nucleic Acid 56 Skin Cancers 56 Prostate Cancer Risk 56 Cell Differentiation 56 virus HBV 56 Scientists Identify 56 Herpes Simplex 56 Lymph Nodes 56 Innate Immunity 56 Carcinomas 56 thyroglobulin 56 Double Blind Randomized 56 Antiretroviral Therapy 56 Human Papillomavirus 56 Neutrophil 56 Chronic Heart Failure 56 Receptor Agonist 56 Reovirus 56 sodium glucose cotransporter 56 Oligonucleotides 56 Annexin 56 colorectal carcinoma 56 Homology 56 polyomavirus 56 Study Casts Doubt 56 Etiology 56 5alpha reductase 56 rs# [002] 56 Immunohistochemical 56 Therapeutic Efficacy 56 Gene Mutations 56 Eur Urol 56 HLA alleles 56 Nucleic Acid Amplification 56 Protein Biomarkers 56 Hospitalized Patients 56 MEK1 56 Alanine 56 monogenic 56 Gastrointestinal Stromal Tumors 56 Polio Virus 56 leiomyomas 56 Predict Risk 56 T#I [002] 56 Potent Anti 56 Patients Treated 56 Sirolimus Eluting Stent 56 Drug Resistant TB 56 LPS induced 56 Long Term Outcomes 56 J Pediatr 56 autosomal recessive 56 IgG antibody 56 Methylation 56 Cause Mortality 56 Randomized Phase II 56 Plasmodium falciparum 56 TP# gene 56 Endocarditis 56 JAK Inhibitor 56 Viral Infections 56 Bacteroides 56 Drug Shows Promise 56 S. enterica 56 Endocrine Therapy 56 Malaria Vaccine 56 DHPLC 56 Enterobacteriaceae 56 Study Demonstrates 56 Demonstrates Potent 56 Babesia 56 Hyperlipidemia 56 germline mutations 56 Preclinical Data 56 Catenin 56 Subset 56 Prophylaxis 56 ST Segment Elevation 56 Epratuzumab 56 calcium calmodulin dependent 56 Cholesterol Levels 56 Uric Acid 56 Effective Treatments 56 TT genotype 56 functional polymorphism 56 Pluripotency 56 RFLP 56 Hemolysis 56 Detect Cancer 56 Diabetic Nephropathy 56 Cardiac Allograft Rejection 56 QTL mapping 56 qRT PCR 56 H. influenzae 56 Abnormality 56 cell adhesion molecule 56 Hematopoietic 56 Hematological Cancers 55 Non Responders 55 herpesviruses 55 Haptoglobin 55 Improved Survival 55 Antibiotic Resistance 55 inducible nitric oxide synthase 55 Artificial Pancreas 55 Pathogenic 55 Zinc Finger 55 Tolerability 55 Attenuated 55 MR Angiography 55 Heart Failure Patients 55 Cognitive Problems 55 porcine circovirus type 55 serum leptin 55 Heterozygous 55 Autoimmune Disease 55 L. pneumophila 55 Oropharyngeal 55 C#BL/#J 55 NS5A 55 Bacterial Infection 55 Demonstrates Efficacy 55 Anopheles gambiae 55 Morphological 55 Cancer Stem Cells 55 C#Y 55 Dry Powder Inhalers 55 Integrase 55 Hormonal Therapy 55 Well Tolerated 55 gene polymorphism 55 HLA B 55 Cancer Vaccines 55 Gene Variation 55 Combination Clinical Trial 55 Ligands 55 Prolongs Life 55 Blood Pressure Lowering 55 Molecular Diagnostic 55 Clusterin 55 Oncolytic 55 papillary RCC 55 IFN α 55 CCR5 delta# 55 Confirmatory Phase 55 Helps Predict 55 Stomach Cancer 55 NNRTI resistant virus 55 Vaccine Shows Promise 55 Investigational Drug 55 MYH9 gene 55 Hormone Receptor Positive 55 Content Outline 55 enteroviral 55 CDKN2A 55 Rearrangements 55 Patients Receiving 55 Breast Cancer Risk 55 Lentiviral 55 gene locus 55 Demonstrates Positive 55 Interferon Gamma 55 Inflammatory Arthritis 55 transgene expression 55 Trichophyton rubrum 55 Lesion 55 CCR5 tropic HIV 55 Glucocorticoid 55 HLA DQ2 55 receptor kinase 55 Y Chromosome 55 acyltransferase 55 Cellular Immunotherapy 55 Neurofibromatosis Type 55 HLA DR 55 #F FDG PET 55 Premenopausal Women 55 Dilated Cardiomyopathy 55 Prostate Cancers 55 CD# CD# 55 Cancer Res 55 Multicenter Trial 55 vivax 55 Controlled Study 55 murine leukemia virus 55 IgG antibodies 55 EGFR mutations 55 Lung Cancer Trial 55 #:#-# [023] 55 Histone Deacetylase 55 Resistant Hypertension 55 Genes Identified 55 Tumor Necrosis Factor 55 ELISPOT 55 Observational Study 55 sequence homology 55 Is Well Tolerated 55 rs# rs# 55 immunohistochemical analysis 55 N. gonorrhoeae 55 tipranavir ritonavir 55 Patients Treated With 55 annexin 55 Suicidality 55 Randomized Controlled Trials 55 Intracellular 55 grade cervical intraepithelial 55 Remote SQL Injection 55 serologic tests 55 Characterize 55 Breast Cancer Metastasis 55 log# copies mL 55 Endothelial 55 Cannabinoid 55 Pancreatic 55 Fibroblast 55 Elevated Levels 55 immunoglobulin genes 55 haematopoietic 55 haplotype 55 mRNA expression 55 MTHFR 55 gene polymorphisms 55 PCR assay 55 Diagnostic Tools 55 CXCR4 expression 55 Multicenter Phase 55 Autoimmune Disorders 55 BiTE Antibody 55 Thyroid Hormone 55 Prospective Cohort Study 55 Psychiatric Disorders 55 Randomized Clinical Trials 55 chromosome #q# [002] 55 Molecular Weight Heparin 55 Chemoradiation 55 neutralizing antibody responses 55 Monoclonal 55 Candida species 55 HSCT 55 Therapeutic Targets 55 LDL Cholesterol 55 Nucleic Acids 55 mutated K ras 55 Recurrence 55 missense mutation 55 Analogs 55 PCa 55 Genetic Determinants 55 apolipoprotein 55 Significantly Improved 55 adipogenic 55 coagulase negative staphylococci 55 Demonstrates Significant 55 murine models 55 IGFBP 55 HLA A2 55 aneuploidies 55 Peroxisome Proliferator Activated Receptor 55 Help Predict 55 Tumor Angiogenesis 55 Predict Response 55 Epstein Barr virus EBV 55 Arrhythmogenic 55 Catheter Ablation 55 Novel Method 55 capsular polysaccharide 55 Adiposity 55 NIDDM 55 Slow Progression 55 Biosynthesis 55 Cyclooxygenase 2 55 Immunohistochemistry 55 CDH1 55 HIV1 55 Protects Against 55 adiponectin concentrations 55 Menopausal Women 55 Respiratory Viruses 55 beta3 55 Figure S4 55 Nonalcoholic fatty liver 55 X Chromosome 55 glycosyltransferase 55 Neonatal Diabetes 55 GNAQ 55 Increased Risk 55 TOP2A 55 Differentially 55 Embryonic Stem Cells 55 K RAS 55 Genetic Tests 55 Lung Cancer Risk 55 Treat Anemia 55 E. faecalis 55 Nicotinic 55 Helicobacter Pylori 55 Hospital Acquired Pneumonia 55 Diagnostic Tests 55 SARS Virus 55 Radiofrequency Ablation 55 Neurogenesis 55 Breast Ovarian Cancer 55 RT qPCR 55 glycogen synthase kinase 55 Sustained Efficacy 55 Androgen 55 TLR antagonist 55 Susceptibility Testing 55 Small Molecule 55 cytochrome b 55 Eradicates 55 Main Outcome Measure 54 Protein Function 54 hydroxylase 54 Demonstrates Statistically Significant 54 gastric carcinogenesis 54 Trichomonas 54 paragangliomas 54 H.pylori 54 Intracerebral Hemorrhage 54 plasmacytoid dendritic cells 54 chromosome #q# [001] 54 Organ Rejection 54 CD8 responses 54 Randomized Clinical Trial 54 demyelinating 54 Hemoglobin Levels 54 V#F mutation 54 NS4A 54 melatonin receptor 54 Coxsackievirus 54 FDA Okays 54 HBeAg negative chronic hepatitis 54 Insulin Glargine 54 Clin Trials 54 C. albicans 54 ESBLs 54 monocytes macrophages 54 MSH2 54 Carotid Stenting 54 Hypertrophy 54 Aptamer 54 Subclinical 54 allelic variants 54 Aneuploidy 54 Preclinical Efficacy 54 claudin 54 Therapeutic Antibody 54 myelofibrosis polycythemia vera 54 Dose Response 54 proliferator activated receptor 54 hypereosinophilic syndrome 54 K ras 54 MDR1 54 Depressive Symptoms 54 somatic mutations 54 heterozygous 54 Antibiotic Use 54 etiologic agent 54 Stem Cell Transplants 54 Prospective Randomized Trial 54 chromosome #q#.# [002] 54 Sequenced 54 gene loci 54 HER2/neu 54 basal cell carcinoma BCC 54 histologic subtype 54 Cortical 54 Contrast Agents 54 Ebola Vaccine 54 EP4 54 parainfluenza virus 54 Gastrointestinal Disorders 54 Mechanistic 54 Flu Strain 54 Liver Failure 54 perilipin 54 Sex Hormones 54 Treating Heart Failure 54 SF #v# 54 Pharmacogenetics 54 JAK2 enzyme 54 Chromosomal 54 ImmunoCAP ® 54 Salivary 54 Homogeneous 54 NSCLC tumors 54 indels 54 #:#-# [037] 54 Chemotherapeutic Agents 54 Calcium Intake 54 Protein Involved 54 isomerase 54 Gene Silencing 54 ribosomal protein 54 Treated Patients 54 Newly Identified 54 virological response 54 Prostate Cancer Progression 54 Therapy Shows Promise 54 Tropism 54 histologic subtypes 54 differentially expressed genes 54 Vitamin D Deficiency 54 Left Atrial 54 HBeAg positive 54 Multiple Myeloma MM 54 Randomized Controlled Trial 54 Radiation Dose 54 protein tyrosine phosphatase 54 Disease Outbreaks 54 downregulation 54 Haemophilus influenza 54 Analyte 54 Intracranial Aneurysms 54 #S rRNA gene 54 F FDG PET 54 Stakeholder Insight 54 Bloodstream Infections 54 Present Preclinical Data 54 Hemoglobin 54 surface proteins hemagglutinin 54 CYP#C# gene 54 Correlates 54 Mammalian 54 Gene Expression Analysis 54 Blood Vessels 54 Antithrombin 54 Sexual Satisfaction 54 haplogroups 54 HBeAg 54 hepatitis C genotype 54 Transdermal Delivery 54 polymorphisms 54 Functional Outcomes 54 Stromal 54 prognostic marker 54 ANCOVA 54 Breast Cancer Stem Cells 54 Leukocyte 54 Renal Tumors 54 Peritoneal 54 Pandemic Flu Vaccine